G D Sebastiani Selected Research

malar rash

10/2015

Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G D Sebastiani Research Topics

Disease

6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2007 - 01/2000
4	Rheumatoid Arthritis 01/2022 - 04/2009
2	Arthritis (Polyarthritis) 08/2018 - 10/2015
2	Infections 04/2009 - 01/2005
2	Heterotopic Ossification (Ectopic Ossification) 05/2002 - 01/2002
2	Coma (Comas) 05/2002 - 01/2002
1	Necrosis 01/2022
1	Leukopenia 03/2019
1	Diarrhea 03/2019
1	Fever (Fevers) 03/2019
1	Hyponatremia 03/2019
1	Oral Ulcer (Mouth Ulcer) 08/2018
1	Exanthema (Rash) 10/2015
1	Serositis 10/2015
1	malar rash 10/2015
1	Ulcer 10/2015
1	Nervous System Diseases (Neurological Disorders) 10/2015
1	Rheumatic Diseases (Rheumatism) 03/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2010
1	Lupus Nephritis 01/2010
1	Proteinuria 01/2010
1	Pericarditis 10/2009
1	autosomal dominant familial Periodic fever 10/2009
1	Viremia 04/2009
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2009
1	Glomerulonephritis 01/2009
1	Vasculitis (Vasculitides) 01/2009
1	Microscopic Polyangiitis 01/2009
1	Inflammation (Inflammations) 01/2006
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2003
1	Pulmonary Embolism 05/2001
1	Migraine Disorders (Migraine) 01/2000
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2000

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 01/2003 - 01/2000
2	Antiphospholipid AntibodiesIBA 10/2015 - 01/2003
2	AutoantibodiesIBA 01/2006 - 01/2000
2	Pharmaceutical PreparationsIBA 05/2002 - 01/2002
1	Biological ProductsIBA 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 01/2022
1	Transaminases (Aminotransferases)IBA 03/2019
1	SS-A antibodiesIBA 08/2018
1	Complement System Proteins (Complement)IBA 10/2015
1	Methotrexate (Mexate)FDA LinkGeneric 10/2014
1	MicroRNAs (MicroRNA)IBA 03/2012
1	Adenosine DeaminaseIBA 07/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2010
1	Azathioprine (Imuran)FDA LinkGeneric 01/2010
1	CreatinineIBA 01/2010
1	SteroidsIBA 10/2009
1	Colchicine FDA LinkGeneric 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2009
1	Peptide Hydrolases (Proteases)FDA Link 01/2009
1	Peroxidase (Myeloperoxidase)IBA 01/2009
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2009
1	Interferon Regulatory FactorsIBA 07/2007
1	DNA (Deoxyribonucleic Acid)IBA 03/2007
1	AntigensIBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	OsteopontinIBA 02/2005
1	HLA-DR Antigens (HLA-DR)IBA 01/2005
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2003
1	Methylprednisolone FDA LinkGeneric 05/2001
1	Immunoglobulin G (IgG)IBA 01/2000
1	GangliosidesIBA 01/2000
1	Immunoglobulin M (IgM)IBA 01/2000

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2009
1	Intra-Articular Injections 05/2001